Authors : Adithya Krishna Kezhupilly Ramakrishanan; Subrahmaniyan Sujitha Lekshmi

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/y6p4wyau

Scribd : https://tinyurl.com/43swft8v

DOI : https://doi.org/10.38124/ijisrt/25aug1557

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Pulmonary embolism(PE), a life-threatening manifestation of venous thromboembolism, is usually given meticulous care in hospitals. However, nowadays, due to the evolution of medicine, it has shifted to so-called outpatient management of this condition. To put this into practice in in-depth knowledge of the factors that support or hinder such management of patients is necessary. Global incidence of PE is rising as exposure to risk factors increases. It has become the 3rd cause of cardiovascular morbidity in Western countries. The review explores the advances in diagnostic tools like D-dimer testing and other tools, and risk stratification to identify low-risk PE patients needed for outpatient management. It also addresses different types of criteria that have to be met, and the anticoagulation regimens required to discharge patients. The review discusses future directions which is focused on telemedicine-guided anticoagulation services, technology-driven care models, all of which focus on improved patient care.

Keywords : “Pulmonary Embolism” “Venous Thromboembolism” “Outpatient Management” “Diagnostic Tools” “Risk Stratification” “Anticoagulants” “Telemedicine”.

References :

1. Shah IK, Merfeld JM, Chun J, Tak T. Pathophysiology and Management of Pulmonary Embolism. Int J Angiol.     2022 Sep 23;31(3):143-149. doi: 10.1055/s-0042-1756204. PMID: 36157092; PMCID: PMC9507564.
2. Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, et al. A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology. Int J Mol Sci. 2023 Feb 5;24(4):3169. doi: 10.3390/ijms24043169. PMID: 36834580; PMCID: PMC9964264.
3. Shan J, Isaacs DJ, Bath H, Johnson EJ, Julien D, Vinson DR. "Outpatient Management" of Pulmonary Embolism Defined in the Primary Literature: A Narrative Review. Perm J. 2021 Jul 28;25:20.303. doi: 10.7812/TPP/20.303. PMID: 35348077; PMCID: PMC8784062.
4. Westafer LM, Jessen E, Zampi M, Boccio E, Casey SD, Lindenauer PK, et al. Barriers and Facilitators to the Outpatient Management of Low-risk Pulmonary Embolism From the Emergency Department. Ann Emerg Med. 2023 Sep;82(3):381-393. doi: 10.1016/j.annemergmed.2023.02.021. Epub 2023 Apr 12. PMID: 37596016; PMCID: PMC10440853.
5. Westafer LM, Shieh MS, Pekow PS, Stefan MS, Lindenauer PK. Outpatient Management of Patients Following Diagnosis of Acute Pulmonary Embolism. Acad Emerg Med. 2021 Mar;28(3):336-345. doi: 10.1111/acem 14181. Epub 2020 Dec 19. PMID: 33248008; PMCID: PMC8221072.
6. Dix C, Tran HA. Pulmonary embolus. Aust J Gen Pract. 2022;51(9):667–671. doi:10.31128/AJGP-05-22-6440
7. Pruszczyk P, Skowrońska M, Ciurzyński M, Kurnicka K, Lankeit M, Konstantinides S. Assessment of pulmonary embolism severity and the risk of early death. Pol Arch Intern Med. 2021;131(12). doi:10.20452/pamw.16134.
8. Pandat S, Nagaura T, Nair SG, Uy-Evanado A, Stecker EC, Nichols GA, et al. An association between right ventricular dysfunction and sudden cardiac death. Heart Rhythm. 2020 Feb;17(2):169–174. doi:10.1016/j.hrthm.2019.10.021. PubMed Central PMCID: PMC8078030.
9. Mudrakola HV, Caples SM, Hyde RJ, McBane RD II, Ahmad SR. Inpatient Management of Pulmonary Embolism: Clinical Characteristics and Mortality in a High-Volume Tertiary Care Center. J Thromb Thrombolysis. 2022 Jan;54(1):145–52. doi: 10.1007/s11239-021-02619-9. PMCID: PMC8754518; PMID: 35022990.
10. Watson NW, Weinberg I, Dicks AB, Fong E, Strom JB, Carroll BJ, et al. Clinical significance of right heart thrombus with and without an associated pulmonary embolism. Am J Med. 2023 Nov;136(11):1109-1118.e3. doi:10.1016/j.amjmed.2023.07.014. Epub 2023 Aug 11. PMID: 37572740; PMCID: PMC10592144.
11. Rodríguez-Cobo A, Fernández-Capitán C, Tung-Chen Y, Salgueiro-Origlia G, Ballaz A, Bortoluzzi C, et al.; RIETE Investigators. Clinical significance and outcome in patients with asymptomatic versus symptomatic subsegmental pulmonary embolism. J Clin Med. 2023 Feb 18;12(4):1640. doi:10.3390/jcm12041640. PMID: 36836176; PMCID: PMC9959177.
12. Doherty S. Pulmonary embolism: An update. Aust Fam Physician. 2017 Nov;46(11):816-20. PMID: 29101916.
13. Khandait H, Harkut P, Khandait V, Bang V. Acute pulmonary embolism: Diagnosis and management. Indian Heart J. 2023 Jul-Aug;75(4):223-229. doi: 10.1016/j.ihj.2023.05.007. PMID: 37207830; PMCID: PMC10568061.
14. Kulka HC, Zeller A, Fornaro J, Wuillemin WA, Konstantinides S, Christ M. Acute pulmonary embolism–its diagnosis and treatment from a multidisciplinary viewpoint. Dtsch Arztebl Int. 2021 Sep 17;118(37):618-28. doi: 10.3238/arztebl.m2021.0226. PMID: 34857082; PMCID: PMC8704819.
15. Ebrahimi M, Arab MM, Zamani Moghadam H, Jalal Yazdi M, Rayat Doost E, Foroughian M. Risk Stratification of Pulmonary Thromboembolism using Brain Natriuretic Peptide and Troponin I; a Brief Report. Arch Acad Emerg Med. 2022 Jan 8;10(1):e8. doi:10.22037/aaem.v10i1.1453. PMID: 35072097; PMCID: PMC8771149.
16. Bi W, Liang S, He Z, Jin Y, Lang Z, Liu H,  et al. The prognostic value of the serum levels of brain natriuretic peptide, troponin I, and D-dimer, in addition to the neutrophil-to-lymphocyte ratio, for the disease evaluation of patients with acute pulmonary embolism. Int J Gen Med. 2021 Jan 28;14:303-8. doi:10.2147/IJGM.S288975. PMID: 33536777; PMCID: PMC7850564.
17. Oh JK, Park JH. Role of echocardiography in acute pulmonary embolism. Korean J Intern Med. 2023 Jul;38(4):456-70. doi:10.3904/kjim.2022.273. Epub 2023 Jan 2. PMID: 36587934; PMCID: PMC10338244.
18. Li L, Peng M, Zou Y, Li Y, Qiao P. The promise and limitations of artificial intelligence in CTPA-based pulmonary embolism detection. Front Med (Lausanne). 2025 Mar 19;12:1514931. doi:10.3389/fmed.2025.1514931. PMID: 40177281; PMCID: PMC11961422.
19. Yaghoobpoor S, Fathi M, Taher HJ, Farhood AJ, Bahrami A, Eshraghi R et al. Computed tomography pulmonary angiography (CTPA) for the detection of pulmonary embolism (PE) among trauma patients: a systematic review and meta-analysis. Emerg Radiol. 2024 Aug;31(4):567-80. doi:10.1007/s10140-024-02249-7. Epub 2024 Jun 7. PMID: 38844660; PMCID: PMC11289063.
20. Leidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk stratification in patients with acute pulmonary embolism: Current evidence and perspectives. J Clin Med. 2022 Apr 30;11(9):2533. doi: 10.3390/jcm11092533. PMID: 35566658; PMCID: PMC9104204.
21. Palas M, Valente Silva B, Jorge C, Almeida AG, Pinto FJ, Caldeira D. The accuracy of Hestia and simplified PESI to predict the prognosis in pulmonary embolism: Systematic review with meta-analysis. TH Open. 2022 Oct 23;6(4):e347–e353. doi: 10.1055/a-1942-2526. PMID: 36452203; PMCID: PMC9593482.
22. Iqbal Mohammed AQ, Berman L, Staroselsky M, Wenn P, Hai O, Makaryus AN, et al. Clinical presentation and risk stratification of pulmonary embolism. Ther Adv Cardiovasc Dis. 2024;18:17539447241258387. doi:10.1055/s-0044-1786878. PMID: 38846996; PMCID: PMC11152639.
23. Brikho S, Zughaib MT, Tsaloff G, Smythe K, Zughaib ME. Evaluating the appropriateness of pulmonary embolism admissions in a community hospital emergency department. Cureus. 2022 Apr 19;14(4):e24292. doi:10.7759/cureus.24292. PMID: 35602808; PMCID: PMC9119667.
24. Silva BV, Calé R, Menezes MN, Jorge C, Pinto FJ, Caldeira D. How to predict prognosis in patients with acute pulmonary embolism? Recent advances. Kardiol Pol. 2023;81(7-8):684-691. doi:10.33963/KP.a2023.0143. PMID: 37366261.
25. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. doi:10.1093/eurheartj/ehz405. PMID: 31504429.
26. Hendriks SV, Bavalia R, van Bemmel T, Bistervels IM, Eijsvogel M, Faber LM, et al. Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS study. Thromb Res. 2020 Sep;193:60-65. doi:10.1016/j.thromres.2020.05.038.
27. Rouleau SG, Balasubramanian MJ, Huang J, Antognini T, Reed ME, Vinson DR. Prevalence of and eligibility for surveillance without anticoagulation among adults with lower-risk acute subsegmental pulmonary embolism. JAMA Netw Open. 2023;6(8):e2326898. doi:10.1001/jamanetworkopen.2023.26898.
28. Bellou E, Keramida E, Karampinis I, Dimakakos E, Misthos P, Demertzis P, Hardavella G. Outpatient treatment of pulmonary embolism. Breathe (Sheff). 2020;16(3):200069. doi:10.1183/20734735.0069-2020.
29. Yoo HHB, Nunes-Nogueira VS, Villas Boas PJF, Broderick C. Outpatient versus inpatient treatment for acute pulmonary embolism. Cochrane Database Syst Rev. 2022 May 5;2022(5):CD010019. doi:10.1002/14651858.CD010019.pub4. PMID: 35511086; PMCID: PMC9070407.
30. Ghazvinian R, Gottsäter A, Elf JL. Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism. J Thromb Thrombolysis. 2018;45(2):319-24. doi:10.1007/s11239-017-1607-9.
31. Pham A, Heib A, Goodman E, Cotto R, Jafari P, Lipsitz E, et al. Warfarin versus direct oral anticoagulants for patients needing distal deep vein thrombosis treatment. J Vasc Surg Venous Lymphat Disord. 2022;10(5):1065-72. doi:10.1016/j.jvsv.2022.01.006.
32. Tu ZH, Perez AD, Diaz TE, Loop MS, Clarke M. Safety and efficacy of direct oral anticoagulants vs warfarin in patients with obesity and venous thromboembolism: a retrospective analysis. Tex Heart Inst J. 2024;51(1):e238260. doi:10.14503/THIJ-23-8260.
33. Al-Maimoony T, Al-Matari K, Al-Habeet A, Aljaber NN, Al-Marwala M, Al-Hashmi S. Efficacy and safety of off-label direct oral anticoagulants vs. warfarin for left ventricular thrombus: an inverse probability of treatment weighting analysis. Front Cardiovasc Med. 2025 Apr 28;12:1465866. doi:10.3389/fcvm.2025.1465866. PMID: 40357438; PMCID: PMC12066775.
34. Hobohm L, Anušić T, Konstantinides SV, Barco S; HoT-PE Investigators. Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial. Eur Respir J. 2020 Oct 8;56(4):2000663. doi:10.1183/13993003.00663-2020. PMID: 32381499.
35. Luijten D, Douillet D, Luijken K, Tromeur C, Penaloza A, Hugli O, et al.Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis. Eur Heart J. 2024 Aug 21;45(32):2933-50. doi:10.1093/eurheartj/ehae378. PMID:38993086; PMCID:PMC11335374.
36. Roy PM, Penaloza A, Hugli O, Klok FA, Arnoux A, Elias A et al. ; HOME-PE Study Group. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. Eur Heart J. 2021 Aug 31;42(33):3146-57. doi: 10.1093/eurheartj/ehab373. PMID: 34363386; PMCID: PMC8408662.
37. Chaibi S, Roy PM, Arnoux Guénégou A, Tran Y, Hugli O, Penaloza A, et al; HOME-PE study group. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial. Thromb Res. 2024;234:1-8. doi: 10.1016/j.thromres.2024.01.014. PMID: 38308882.
38. van Es N, Takada T, Kraaijpoel N, Klok FA, Stals MAM, Büller HR, et al. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis. Eur Heart J. 2023 Aug 22;44(32):3073-3081. doi: 10.1093/eurheartj/ehad417. PMID: 37452732; PMCID: PMC10917087.
39. Mohanarajan M, Salunke PP, Arif A, Iglesias Gonzalez PM, Ospina D, et al. Advancements in Machine Learning and Artificial Intelligence in the Radiological Detection of Pulmonary Embolism. Cureus. 2025 Jan 29;17(1):e78217. doi: 10.7759/cureus.78217. PMID: 40026993; PMCID: PMC11872007.
40. Keller K, Göbel S, Ten Cate V, Panova-Noeva M, Eggebrecht L, Nagler M, et. al. Telemedicine-Based Specialized Care Improves the Outcome of Anticoagulated Individuals with Venous Thromboembolism-Results from the thrombEVAL Study. J Clin Med. 2020 Oct 13;9(10):3281. doi: 10.3390/jcm9103281. PMID: 33066188; PMCID: PMC7602093.
41. Kholmukhamedov A, Subbotin D, Gorin A, Ilyassov R. Anticoagulation Management: Current Landscape and Future Trends. J Clin Med. 2025 Feb 28;14(5):1647. doi: 10.3390/jcm14051647. PMID: 40095578; PMCID: PMC11900363.
42. Vinereanu D, Lopes RD, Mulder H, White HD, Alexander JH, Hanna M, et al. Outcomes in anticoagulated patients with atrial fibrillation and with coronary artery disease: insights from the ARISTOTLE trial. Front Cardiovasc Med. 2021;8:648265. doi:10.3389/fcvm.2021.648265.